An estimated 170,000 Australians were diagnosed with cancer in 2025. Many people know the causes of cancer are partly genetic. But how do your genes, which contribute so much of what makes you you, ...

A large international study has mapped the genetic landscape of feline cancers for the first time, revealing striking similarities between tumor-driving mutations in cats, humans, and dogs.

Imagine a tiny superhero inside every cell of your body whose job is to stop damaged cells before they turn dangerous. That superhero is a gene called TP53, and for decades scientists have known it as ...

Whitney Maxwell, MS, CGC, stands at the helm of the Inherited Cancer Research Shared Resource at Huntsman Cancer Institute at the University of Utah, overseeing a dynamic team of genetic counselors, ...

When people ask "is cancer a genetic disease?" they are often thinking about family history: if my parent had cancer, will I? The short answer is complicated but important: cancer is driven by genetic ...

Cancer genetics is the field that elucidates how genetic and epigenetic alterations drive the transformation of normal cells into malignant tumours. At its core, cancer is a genetic disease, arising ...

Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...

Of the many advances in science and technology over the past 25 years, genetic testing is arguably one of the most notable. Once a rare part of health care, it is now becoming much more common. It’s ...

Breast cancer is the most common cancer among women, making up 30% of all new cases each year. Knowledge is power when it comes to detection and prevention of this disease: Genetic testing can play an ...

Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics, now a wholly owned subsidiary of Tempus AI, Inc. (NASDAQ: TEM) company and a leader in clinical genomic testing, announced today that a ...